bf/NASDAQ:RNA_icon.jpeg

COM:AVIDITYBIOSCIENCES

Avidity Biosciences

  • Stock

Last Close

42.56

22/11 21:00

Market Cap

5.16B

Beta: -

Volume Today

993.16K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-11.22M
-
-24.73M
120.52%
-44.35M
79.33%
-118.01M
166.06%
-174.00M
47.44%
-212.22M
21.97%
depreciation and amortization
383K
-
348K
9.14%
373K
7.18%
639K
71.31%
1.39M
117.06%
2.10M
51.48%
deferred income tax
84K
-
-1.77M
-
stock based compensation
60K
-
406K
576.67%
4.31M
961.58%
17.06M
295.73%
27.14M
59.12%
38.22M
40.84%
change in working capital
671K
-
19.12M
2,749.93%
2.33M
87.81%
5.34M
128.90%
9.82M
83.89%
61.13M
522.75%
accounts receivables
inventory
accounts payables
451K
-
5.75M
1,174.72%
6.04M
5.11%
18.32M
203.08%
1.77M
90.34%
other working capital
671K
-
18.67M
2,682.71%
-3.42M
118.30%
-705K
79.37%
-8.50M
1,105.53%
59.36M
798.44%
other non cash items
447K
-
7.35M
1,543.62%
139K
98.11%
163K
17.27%
-615K
477.30%
-6.53M
961.30%
net cash provided by operating activities
-9.65M
-
2.49M
125.79%
-37.12M
1,590.64%
-94.81M
155.44%
-136.27M
43.72%
-119.06M
12.63%
investments in property plant and equipment
-49K
-
-235K
379.59%
-1.09M
364.68%
-3.74M
242.49%
-2.82M
24.52%
-4.23M
49.77%
acquisitions net
82.52M
-
187.13M
126.78%
purchases of investments
-6.69M
-
-85.36M
1,175.32%
-355.84M
316.88%
-461.00M
29.55%
sales maturities of investments
6.58M
-
168.71M
2,463.91%
335.16M
98.67%
other investing activites
-82.52M
-
-187.13M
126.78%
net cash used for investing activites
-49K
-
-235K
379.59%
-7.79M
3,212.77%
-82.52M
959.95%
-189.96M
130.20%
-130.07M
31.53%
debt repayment
-2.80M
-
-4.68M
67.25%
common stock issued
65K
-
298.08M
458,484.62%
185.94M
37.62%
344.78M
85.43%
93.86M
72.78%
common stock repurchased
444K
-
dividends paid
-106K
-
-444K
318.87%
other financing activites
92.07M
-
-21.36M
123.20%
-9.62M
54.95%
1.39M
114.47%
net cash used provided by financing activities
5.14M
-
89.23M
1,634.70%
272.04M
204.86%
176.32M
35.19%
346.17M
96.34%
93.86M
72.89%
effect of forex changes on cash
-44K
-
net change in cash
-4.56M
-
91.49M
2,106.32%
227.13M
148.27%
-1.01M
100.45%
19.95M
2,067.26%
-155.31M
878.59%
cash at beginning of period
7.65M
-
3.09M
59.61%
94.58M
2,960.78%
321.71M
240.16%
320.70M
0.32%
340.40M
6.14%
cash at end of period
3.09M
-
94.58M
2,960.78%
321.71M
240.16%
320.70M
0.32%
340.65M
6.22%
185.08M
45.67%
operating cash flow
-9.65M
-
2.49M
125.79%
-37.12M
1,590.64%
-94.81M
155.44%
-136.27M
43.72%
-119.06M
12.63%
capital expenditure
-49K
-
-235K
379.59%
-1.09M
364.68%
-3.74M
242.49%
-2.82M
24.52%
-4.23M
49.77%
free cash flow
-9.70M
-
2.25M
123.24%
-38.21M
1,794.41%
-98.55M
157.93%
-139.09M
41.13%
-123.29M
11.36%

All numbers in (except ratios and percentages)